share_log

BRIEF-Fortress Biotech’s Partner Company, Journey Medical Corp, In-Licenses And Launches Accutane

路透社 ·  Mar 22, 2021 21:09
March 22 (Reuters) - Fortress Biotech Inc :
   * FORTRESS BIOTECH - JOURNEY MEDICAL CORPORATION IN-LICENSED & LAUNCHED AN ORAL ISOTRETINOIN UNDER BRAND NAME ACCUTANE IN U.S.

Source text for Eikon:  Further company coverage:

((Reuters.Briefs@thomsonreuters.com;)
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment